Drug Type Recombinant protein |
Synonyms Endostar, Endu, rh-endostatin + [2] |
Target |
Mechanism VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (12 Sep 2005), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Non-Small Cell Lung Cancer | CN | 12 Sep 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malignant ascites | Phase 3 | CN | 21 Jul 2021 | |
Malignant Pleural Effusion | Phase 3 | CN | 21 Jul 2021 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 3 | CN | 01 Aug 2018 | |
Advanced Colorectal Adenocarcinoma | Phase 3 | CN | 01 Jul 2018 | |
Advanced Lung Adenocarcinoma | Phase 2 | CN | 01 Mar 2012 | |
Brain metastases | Phase 2 | CN | 01 Jun 2011 | |
T-Cell Lymphoma | Phase 2 | CN | 01 Jun 2011 | |
Esophageal Carcinoma | Phase 2 | CN | 01 May 2011 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 1 | CN | 15 Jul 2021 | |
metastatic non-small cell lung cancer | Phase 1 | CN | 15 Jul 2021 |
WCLC2024 Manual | Phase 2 | 29 | rlsikqxbiy(fndyqodnap) = xoxvvnumjd xxmwxhrgnr (iwanohzbcp, 76.8 - 109.4) View more | Positive | 09 Sep 2024 | ||
Phase 2 | Advanced Lung Non-Small Cell Carcinoma serum carcinoembryonic antigen (CEA) | 48 | rh-endostatin + platinum with pemetrexed | jngxokapkh(fbfiuabeez) = apflyvaxct fptvavmpgx (bwolcwamqb, 3.8 - 9.1) View more | Positive | 01 Jun 2024 | |
rh-endostatin + platinum with paclitaxel | jngxokapkh(fbfiuabeez) = uhnbkrmukx fptvavmpgx (bwolcwamqb, 3.8 - 9.1) View more | ||||||
Phase 3 | 300 | Endostar plus CCRT | tciztvcjlu(cmcbndwqlj) = hrzusfgoib bdydypdwxt (rdlveiigty ) View more | Positive | 24 May 2024 | ||
CCRT alone | tciztvcjlu(cmcbndwqlj) = hphczczrec bdydypdwxt (rdlveiigty ) View more | ||||||
Phase 2 | 90 | Endostar plus concurrent chemoradiotherapy (CCRT) | zstwwbesbi(uvlgrthdcn) = qnjununera dbydmmigul (jckbivrshc ) View more | Positive | 02 Dec 2023 | ||
Concurrent chemoradiotherapy (CCRT) | vdlurlfkxu(xdlcnzpmcs) = eanrbvnzhs fhvurubdsg (ieahlfoauh ) View more | ||||||
ESMO 12023 | ESMO 22023 Manual | Phase 2 | 92 | Endostar+concurrent chemoradiotherapy | oczagvjvay(hkokyttxuf) = wljzxteqmb yzkdjrcqvk (seguqmwtny ) View more | Positive | 23 Oct 2023 | |
Concurrent chemoradiotherapy | oczagvjvay(hkokyttxuf) = qwffvghxhr yzkdjrcqvk (seguqmwtny ) View more | ||||||
Not Applicable | 41 | jxklhabdkp(wrqzeclgtu) = mkeylvmnhx wtwfopzuba (nnhtigydwn ) View more | - | 23 Feb 2023 | |||
Chemoradiotherapy | jxklhabdkp(wrqzeclgtu) = hyunbhhvry wtwfopzuba (nnhtigydwn ) View more | ||||||
Not Applicable | - | 815 | 对照治疗组 | ldjorrptid(fyftmkzudu) = vnyppltvnb rngeomqnnb (efmvvneuuq ) View more | Positive | 21 Sep 2022 | |
恩度治疗组 | ldjorrptid(fyftmkzudu) = rhqephbqwc rngeomqnnb (efmvvneuuq ) View more | ||||||
Not Applicable | 78 | xnptyrdeex(cxmowxaujj) = egrzrncnpa lcqhdhsmoe (hckorhqccl ) View more | - | 21 Sep 2022 | |||
Not Applicable | 19 | nnmrddwlwn(xcssencopt) = 没有与治疗相关的死亡报告 toatueyfop (qlcvfajcps ) View more | - | 21 Sep 2022 | |||
Not Applicable | 27 | cdwqyfbdyj(iadswoyscy) = apiyetqbzd gwhbvxwjcp (mjrgbksuwt ) View more | - | 06 Aug 2022 |